Provided by Tiger Trade Technology Pte. Ltd.

Haemonetics

102.69
+1.631.61%
Post-market: 102.690.00000.00%19:30 EDT
Volume:458.31K
Turnover:46.77M
Market Cap:4.67B
PE:50.09
High:102.89
Open:101.70
Low:100.53
Close:101.06
52wk High:109.57
52wk Low:47.32
Shares:45.45M
Float Shares:44.60M
Volume Ratio:0.81
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.05
EPS(LYR):2.05
ROE:11.20%
ROA:6.60%
PB:5.58
PE(LYR):50.09

Loading ...

Haemonetics Raised to Buy From Neutral by B of A Securities

Dow Jones
·
May 22

BofA Securities Upgrades Haemonetics to Buy From Neutral, Price Target is $80

MT Newswires Live
·
May 22

Haemonetics upgraded to Buy from Neutral at BofA

TIPRANKS
·
May 22

Haemonetics’ Global ERP Rollout Poses Execution Risks, Potential Margin Pressure and Operational Disruption

TIPRANKS
·
May 22

Haemonetics FY26 net income drops 42% to $97.31 million; revenue slips 2% to $1.33 billion

Reuters
·
May 20

Haemonetics (HAE) Valuation Check As Earnings Pressure And Options Volatility Raise Questions

Simply Wall St.
·
May 18

BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026

GlobeNewswire
·
May 13

Haemonetics Is Maintained at Outperform by Barrington Research

Dow Jones
·
May 13

Press Release: Pharvaris Reports First Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 13

Barrington Cuts Price Target on Haemonetics to $89 From $94, Keeps Outperform Rating

MT Newswires Live
·
May 12

Haemonetics Earnings Call Highlights Growth Amid Headwinds

TIPRANKS
·
May 09

Haemonetics Is Maintained at Neutral by JP Morgan

Dow Jones
·
May 09

Haemonetics price target lowered to $67 from $72 at Baird

TIPRANKS
·
May 09

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Haemonetics (HAE), Scholar Rock Holding (SRRK) and Ocugen (OCGN)

TIPRANKS
·
May 08

Stock Track | Haemonetics Soars 8.22% in Pre-market on Strong Q4 Earnings Beat and Upbeat Fiscal 2027 Guidance

Stock Track
·
May 07

Earnings Flash (HAE) Haemonetics Posts Fiscal Q4 Net Revenue $346.4M, vs. FactSet Est of $336.8M

MT Newswires Live
·
May 07

Haemonetics Corp Q4 REV View $336.9 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
May 07

Haemonetics Corp - Fiscal 2027 Guidance Reported Revenue 4% - 7% - SEC Filing

THOMSON REUTERS
·
May 07

Haemonetics Corp -Fiscal 2027 Guidance Adjusted Earnings per Diluted Share Is Comparable to Revenue Growth- SEC Filing

THOMSON REUTERS
·
May 07

Haemonetics Q4 Adj. EPS $1.29 Beats $1.27 Estimate, Sales $346.351M Beat $336.862M Estimate

Benzinga Earnings
·
May 07